Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab trial for desensitization and antibody-mediated rejection in kidney transplantation
jRCTs031180323Completed
- Start
- Dec 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of rituximab in chronic kidney disease (CKD), Antibody-mediated rejection of kidney allograft (ABMR) and Renal transplant with donor-specific HLA antibodies (2 arms). Started Dec 2013; status: completed.
02
Drugs
rituximab
03
Conditions
chronic kidney disease (CKD)Antibody-mediated rejection of kidney allograft (ABMR)Renal transplant with donor-specific HLA antibodies
Beyond the preview
Go deeper on jRCTs031180323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180323.